Embryoid Body-Explant Outgrowth Cultivation from Induced Pluripotent Stem Cells in an Automated Closed Platform
- PMID: 27648449
- PMCID: PMC5018318
- DOI: 10.1155/2016/7098987
Embryoid Body-Explant Outgrowth Cultivation from Induced Pluripotent Stem Cells in an Automated Closed Platform
Abstract
Automation of cell culture would facilitate stable cell expansion with consistent quality. In the present study, feasibility of an automated closed-cell culture system "P 4C S" for an embryoid body- (EB-) explant outgrowth culture was investigated as a model case for explant culture. After placing the induced pluripotent stem cell- (iPSC-) derived EBs into the system, the EBs successfully adhered to the culture surface and the cell outgrowth was clearly observed surrounding the adherent EBs. After confirming the outgrowth, we carried out subculture manipulation, in which the detached cells were simply dispersed by shaking the culture flask, leading to uniform cell distribution. This enabled continuous stable cell expansion, resulting in a cell yield of 3.1 × 10(7). There was no evidence of bacterial contamination throughout the cell culture experiments. We herewith developed the automated cultivation platform for EB-explant outgrowth cells.
Figures
References
-
- Tran C. A., Burton L., Russom D., et al. Manufacturing of large numbers of patient-specific T cells for adoptive immunotherapy: an approach to improving product safety, composition, and production capacity. Journal of Immunotherapy. 2007;30(6):644–654. doi: 10.1097/cji.0b013e318052e1f4. - DOI - PubMed
-
- Okano T., Sawa Y., Barber E., Umezawa A. Regenerative therapy by fusion of medicine and engineering: first-in-human clinical trials with induced pluripotent stem cells and cell sheet technology: a report of the Symposium of Regenerative Medicine for Patients. Regenerative Therapy. 2015;2:2–5. doi: 10.1016/j.reth.2015.07.002. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
